Literature DB >> 12149042

Prevention or retardation of joint damage in rheumatoid arthritis: issues of definition, evaluation and interpretation of plain radiographs.

Maarten Boers1, Désirée M F M van der Heijde.   

Abstract

This article discusses methodological concepts and challenges underlying the interpretation of changes in plain radiographs of the joints of patients with rheumatoid arthritis. A series of consensus conferences (OMERACT [Outcome Measures in Rheumatology]) has resulted in the formulation and execution of a research agenda to harmonise reading and interpretation of films. This is important in the light of the increasing evidence that drugs can impact on the progression of joint damage. In these conferences, methodological issues have been divided according to applicability tenets summarised in the OMERACT Filter of Truth, Discrimination, and Feasibility. To pass the Filter, a measure must measure what it is supposed to measure (Truth), must discriminate between clinically relevant states (Discrimination) and be feasible in terms of costs and interpretability. 'Truth' issues include the choice of joints, the view and other technical specifications of the radiograph, such as which abnormalities to score, the level of aggregation of the information, culminating in the choice of the scoring system. 'Discrimination' issues include reproducibility and sensitivity to change. The current research agenda includes items such as defining a criterion for 'no relevant progression', comparison between time ordered and randomly ordered reading, further comparison of methods and subscores, and methodology around missing values.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149042     DOI: 10.2165/00003495-200262120-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  30 in total

1.  Imaging in rheumatoid arthritis: results of group discussions.

Authors:  E T Molenaar; M Boers; D M van der Heijde; G Alarcón; B Bresnihan; M Cardiel; J Edmonds; D Felson; D E Furst; J Kirwan; M Lassere; H Paulus; R Rau; P L van Riel; D Scott; L Simon; V Strand
Journal:  J Rheumatol       Date:  1999-03       Impact factor: 4.666

2.  How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion.

Authors:  Désirée van der Heijde; Lee Simon; Josef Smolen; Vibeke Strand; John Sharp; Maarten Boers; Ferdinand Breedveld; Michael Weisman; Michael Weinblatt; Rolf Rau; Peter Lipsky
Journal:  Arthritis Rheum       Date:  2002-04-15

3.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

4.  Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Authors:  M Boers; A C Verhoeven; H M Markusse; M A van de Laar; R Westhovens; J C van Denderen; D van Zeben; B A Dijkmans; A J Peeters; P Jacobs; H R van den Brink; H J Schouten; D M van der Heijde; A Boonen; S van der Linden
Journal:  Lancet       Date:  1997-08-02       Impact factor: 79.321

Review 5.  Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability.

Authors:  D M van der Heijde
Journal:  Baillieres Clin Rheumatol       Date:  1996-08

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 7.  Methodological issues in radiographic scoring methods in rheumatoid arthritis.

Authors:  D van der Heijde; M Boers; M Lassere
Journal:  J Rheumatol       Date:  1999-03       Impact factor: 4.666

8.  The hierarchy of outcome assessment.

Authors:  J F Fries
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

9.  Proposed modification to Larsen's scoring methods for hand and wrist radiographs.

Authors:  D L Scott; D A Houssien; L Laasonen
Journal:  Br J Rheumatol       Date:  1995-01

Review 10.  Measurements of rheumatoid arthritis disease activity and damage using magnetic resonance imaging. Truth and discrimination: does MRI make the grade?

Authors:  M N Lassere; P Bird
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

View more
  2 in total

Review 1.  Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritis.

Authors:  Gabriel Baron; Isabelle Boutron; Bruno Giraudeau; Philippe Ravaud
Journal:  Ann Rheum Dis       Date:  2006-12-11       Impact factor: 19.103

Review 2.  Biological agents for rheumatoid arthritis: targeting both physical function and structural damage.

Authors:  Alice Klinkhoff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.